Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Unity Biotechnology Inc (UBX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8165
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:32
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Unity Biotechnology Inc (Unity Biotechnology), formerly Forge Inc is a biotechnology company that researches, develops and commercializes therapeutics for the treatment of age-related diseases. The company focuses on the development of senolytic medicines to eliminate senescent cells. The company’s product portfolio includes UBX0101, intended for musculoskeletal diseases; and UBX1967, for ophthalmologic diseases, including diabetic retinopathy and diabetic macular edema, glaucoma and age-related macular degeneration. Unity Biotechnology is also developing products for idiopathic pulmonary fibrosis, systemic sclerosis, chronic obstructive pulmonary disease, cognition and kidney disease. The company works in collaboration with research institutions, academic, contract research organizations to develop its product portfolio. Unity Biotechnology is headquartered in Brisbane, California, the US.

Unity Biotechnology Inc (UBX) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Unity Biotech Raises USD55 Million in Series C Financing 11
Unity Biotech Raises Additional USD35 Million in Series B Financing 13
UNITY Biotech Raises USD116 Million in Series B Financing 15
Unity Biotechnology Raises Funds in Venture Financing 17
Partnerships 18
Ascentage Pharma Enters Agreement with Unity Biotechnology 18
Equity Offering 19
Unity Biotech Raises USD85 Million in IPO of Shares 19
Debt Offering 20
Unity Biotechnology Raises USD4 Million in Public Offering of 5% Notes Due 2017 20
Unity Biotechnology Inc – Key Competitors 21
Unity Biotechnology Inc – Key Employees 22
Unity Biotechnology Inc – Locations And Subsidiaries 23
Head Office 23
Recent Developments 24
Financial Announcements 24
Aug 09, 2018: Unity Biotechnology announces second quarter 2018 financial results 24
Jun 07, 2018: UNITY Biotechnology Reports First Quarter 2018 Financial Results 25
Corporate Communications 26
Jun 13, 2018: UNITY Biotechnology added to Russell 3000, 2000 and MicroCap Indexes 26
May 14, 2018: UNITY Biotechnology names Camille Landis as senior vice president of corporate development 27
Mar 27, 2018: UNITY Biotechnology Appoints Pharmaceutical Industry Executive Paul L. Berns to Board of Directors 28
Feb 07, 2018: UNITY Biotechnology Adds David L. Lacey As Board Director 29
Sep 21, 2017: UNITY Biotechnology Appoints Additional Biotech Industry Veterans to Executive Team 30
Product News 31
Jul 09, 2018: First patient treated with drug based on Buck research 31
Appendix 32
Methodology 32
About GlobalData 32
Contact Us 32
Disclaimer 32

List of Tables
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Unity Biotech Raises USD55 Million in Series C Financing 11
Unity Biotech Raises Additional USD35 Million in Series B Financing 13
UNITY Biotech Raises USD116 Million in Series B Financing 15
Unity Biotechnology Raises Funds in Venture Financing 17
Ascentage Pharma Enters Agreement with Unity Biotechnology 18
Unity Biotech Raises USD85 Million in IPO of Shares 19
Unity Biotechnology Raises USD4 Million in Public Offering of 5% Notes Due 2017 20
Unity Biotechnology Inc, Key Competitors 21
Unity Biotechnology Inc, Key Employees 22

List of Figures
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Unity Biotechnology Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Unity Biotechnology Inc (UBX):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Daido Steel Co., Ltd.:企業の戦略・SWOT・財務分析
    Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Daido Steel Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Covestro AG (1COV):企業の財務・戦略的SWOT分析
    Covestro AG (1COV) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Nuo Therapeutics Inc (NUOTQ)-医療機器分野:企業M&A・提携分析
    Summary Nuo Therapeutics Inc (Nuo Therapeutics) is a biomedical company, which specializes in biodynamic therapies in the area of wound care. It focuses on commercializing cell-based technologies, which bind the regenerative capacity of the human body to trigger natural healing. The company's flagsh …
  • Taylor-DeJongh Inc:企業の戦略・SWOT・財務分析
    Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report Summary Taylor-DeJongh Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Ponti’s Group Limited:企業の戦略・SWOT・財務情報
    Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report Summary Ponti's Group Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Aon Plc:企業の戦略・SWOT・財務分析
    Aon Plc - Strategy, SWOT and Corporate Finance Report Summary Aon Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • Rabigh Refining & Petrochemical Co (2380):企業の財務・戦略的SWOT分析
    Rabigh Refining & Petrochemical Co (2380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strength …
  • Pan Orient Energy Corp (POE):石油・ガス:M&Aディール及び事業提携情報
    Summary Pan Orient Energy Corp (POE) is an independent upstream oil and gas company. The company has interests in onshore oil and gas assets in Thailand and Indonesia. It also has interests in Andora Energy Corporation, which holds properties in Northern Alberta. Its assets in Thailand include Conce …
  • Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis – Q3, 2017
    Orsted AS Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2017 Summary Orsted AS (Orsted) formerly Dong Energy A/S, is an integrated energy company that procures, produces, distributes and trades energy and energy related products. It generates electricity and heat using conv …
  • Inflection Biosciences Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Inflection Biosciences Ltd (Inflection Biosciences) is a drug development company focused on discovery and development of small molecule therapeutics for the treatment of cancer. The company’s pipeline products include dual mechanism kinase inhibitors and pim kinase inhibitors including IBL- …
  • Ryosan Company, Ltd
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Dairy Crest Group plc:企業の戦略・SWOT・財務情報
    Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report Summary Dairy Crest Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ventana Medical Systems Inc-製薬・医療分野:企業M&A・提携分析
    Summary Ventana Medical Systems Inc (VMS), a subsidiary of F. Hoffmann-La Roche Ltd is a manufacturer of tissue-based diagnostic solutions for healthcare market. The company develops cancer diagnostic solutions for breast pathology, cervical diagnostics, colorectal pathology, special stains, lung pa …
  • Marriott Vacations Worldwide Corporation:企業の戦略・SWOT・財務情報
    Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report Summary Marriott Vacations Worldwide Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT …
  • Reata Pharmaceuticals Inc (RETA):企業の財務・戦略的SWOT分析
    Summary Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company that develops innovative medicines for the treatment of serious and life-threatening diseases. The company’s clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription fa …
  • Mediware Information Systems Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Mediware Information Systems Inc (Mediware), a subsidiary of TPG Capital is a healthcare solutions company that designs, develops and commercializes specialized healthcare software. It provides software to healthcare and human service providers and payers. The company’s portfolio of solution …
  • Cranswick plc:企業の戦略・SWOT・財務情報
    Cranswick plc - Strategy, SWOT and Corporate Finance Report Summary Cranswick plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Novo Nordisk AS (NOVO B):医療機器:M&Aディール及び事業提携情報
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Pedernales Electric Cooperative, Inc.:企業の戦略的SWOT分析
    Pedernales Electric Cooperative, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and maj …
  • Entergy Corporation:企業の戦略・SWOT・財務情報
    Entergy Corporation - Strategy, SWOT and Corporate Finance Report Summary Entergy Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆